跳至主要内容
临床试验/NCT01626612
NCT01626612已完成3 期

De-escalation of Empirical Antimicrobial Therapy Study in Severe Sepsis: A Randomized Clinical Trial (DEA Study)

Assistance Publique Hopitaux De Marseille2 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2012年2月1日最近更新:
适应症
干预措施

试验速览

阶段
3 期
状态
已完成
入组人数
120
试验地点
2
主要终点
the length of stay

研究概览

简要总结

Rational: Severe sepsis is one of the leading cause of mortality in intensive care unit patients. Early initiation of an appropriate empirical antimicrobial therapy is associated with improved outcomes. In order to avoid an increase of selection pressure and the emergence of multidrug resistant pathogens, guidelines recommend to streamline the antimicrobial therapy after the identification of the pathogen responsible for infection. This strategy has been evaluated in several observational studies. However, at the bedside, few randomized clinical trials tested this strategy prospectively.

Method: the investigators conduct a randomized clinical trial comparing a strategy based on de-escalation (streamlining of the empirical antimicrobial therapy) and a conservative strategy (continuation of the empirical antimicrobial therapy). The investigators first aim was to show that a strategy based on de-escalation is not inferior to a conservative strategy in terms of intensive care unit length of stay. Secondary aims are to compare the rate of mortality rate, the emergence of multidrug resistant pathogens, and the feasibility of de-escalation. The study is performed in nine intensive care units from four institutions, and 120 patients are required to validate the investigators hypothesis. New technologies for the rapid diagnosis of severe infections are investigated in an ancillary study.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Major Subject;
  • Subject having a sepsis engraves(burns) defined according to the following criteria during the initiation of the probability antibiotic treatment:
  • Criteria of SIRS [ 14 ],
  • And a suspected infection,
  • And a failure of organ: low blood pressure, respiratory failure, coma, hepatic insufficiency, renal insufficiency, thrombopénia, spontaneous extension of the TCA,
  • Subject for which an antibiotic treatment was begun within 6 hours following the diagnosis of sepsis engraves(burns);
  • Subject for which a taking with microbiological aim was made within 48 hours following the diagnosis of sepsis

排除标准

  • Minor Subject, pregnant or breast-feeding woman;
  • Neutropénia (PN < 1000 / mm3);
  • Absence of identification of a microorganism in the microbiological examinations;
  • Absence of Social Security;
  • Subject deprived of freedom or under guardianship;
  • Subject for which the lit(enlightened) consent is not collected(taken in) (itself and/or reliable person).

研究组 & 干预措施

a strategy based on de-escalation

Experimental

干预措施: streamlining of the empirical antimicrobial therapy (Procedure)

a conservative strategy

Active Comparator

干预措施: continuation of the empirical antimicrobial therapy (Procedure)

结局指标

主要结局

the length of stay

时间窗: 24 months

he deadline in days sold enters the diagnosis of sepsis engrave or toxic shock and the exit of resuscitation.

次要结局

  • Lasted administration of catécholamines(24 months)
  • Lasted mechanical ventilation(breakdown)(24 months)
  • Mortality in resuscitation(24 months)
  • Lasted treatment antibiotic(24 MONTHS)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验